These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6803747)

  • 1. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
    Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
    Maudgal PC; De Clercq E; Huyghe P
    Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E
    Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal epithelial dysplasia after trifluridine use.
    Maudgal PC; Van Damme B; Missotten L
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(1):6-12. PubMed ID: 6403411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and topical treatment of experimental herpes simplex iritis with bromovinyldeoxyuridine.
    Maudgal PC; Uyttebroeck W; De Clercq E; Missotten L
    Arch Ophthalmol; 1982 Aug; 100(8):1337-40. PubMed ID: 6808980
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():193-9. PubMed ID: 1650667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
    Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis.
    Maudgal PC; Vrijghem JC; Molemans M; Missotten L
    Arch Ophthalmol; 1985 Sep; 103(9):1389-92. PubMed ID: 3929753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.
    Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
    Br J Ophthalmol; 1991 Nov; 75(11):649-51. PubMed ID: 1751456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: a double blind controlled study.
    Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
    Curr Eye Res; 1991; 10 Suppl():183-7. PubMed ID: 1907535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
    Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
    Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
    Rajcáni J; Reefschläger J
    Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cidofovir and experimental herpetic stromal disease.
    Kaufman HE; Varnell ED; Thompson HW
    Arch Ophthalmol; 1999 Jul; 117(7):925-8. PubMed ID: 10408458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
    Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
    Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interferon alpha A or alpha D and trifluridine treatment for herpetic keratitis in rabbits.
    Trousdale MD; Nesburn AB
    Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):480-3. PubMed ID: 6423563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.